Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 5, 2002, Pages 468-473

  Petrioli, Roberto ^a   Coratti, Andrea ^a   Correale, Pierpaolo ^a   D'Aniello, Carlo ^a   Grimaldi, Luca ^a   Tanzini, Gabriello ^a   Civitelli, Serenella ^a   Marsili, Stefania ^a   Messinese, Simona ^a   Marzocca, Giuseppe ^a   Pirtoli, Luigi ^a   Francini, Guido ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Epirubicin; Ifosfamide; Sarcoma

Indexed keywords

EPIRUBICIN; IFOSFAMIDE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HIGH RISK POPULATION; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE SARCOMA; STOMATITIS; TREATMENT OUTCOME; VOMITING;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; EPIRUBICIN; FEMALE; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; SARCOMA; SURVIVAL ANALYSIS;

EID: 0036793736     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200210000-00009     Document Type: Article

References (21)

1. Wingo PA, Tong T, Bolden S. Cancer statistics. CA Cancer J Clin 1995;45:8-30.
2. Suit HD, Mankin HJ, Wood WC. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer 1985;55:2659-67.
3. Wiklund TA, Alvegfird TA, Mouridsen HT, et al. Marginal surgery and postoperative radiotherapy in soft tissue sarcomas. Eur J Cancer 1993;29A:306-9.
4. Chang AE, Kinsella TJ, Glatstein E, et al. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol 1988;6:1491-50.
5. Bramwell V, Rouesse J, Steward W, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma. Reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer. Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994;12:1137-49.
6. Tierney JF, Mosseri V, Stewart LA, et al. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analyses of the published results of randomized clinical trials. Br J Cancer 1995;72:469-75.
7. Costa J, Wesley R, Glatstein E, et al. The grading of soft tissue sarcoma: results of a chemo-histopathologic correlation in a series of 163 cases. Cancer 1984;53:530-41.
8. Lawrence W Jr, Neifeld JP, Terz JJ. Manual of soft tissue tumor surgery. New York: Springer-Verlag, 1983.
9. Enneking WF. Musculoskeletal tumor surgery. New York: Churchill Livingstone, 1983.
10. Toma S, Palumbo R, Sogno G, et al. Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult advanced soft tissue sarcomas. Ann Oncol 1992;3:S119-23.
11. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. Elias A. The clinical management of soft tissue sarcomas. Semin Oncol 1992;19:19-25.
13. Santoro A, Tusez T, Mouridsen H, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcoma: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995;13:1537-45.
14. Steward WP, Verweij J, Somers R, et al. Granulocyte macrophage colony-stimulating factor allows safe escalation of dose intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1993;11:15-21.
15. Edmonson JH, Fleming TR, Ivins JC, et al. Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. J Clin Oncol 1984;2:1390-6.
16. Eilber FR, Giuliano AE, Huth JF, et al. A randomized prospective trial using postoperative chemotherapy (adriamycin) in high grade extremity soft-tissue sarcoma. Am J Clin Oncol 1988;11:39-45.
17. Alvegård TA, Sigurdsson H, Mouridsen H, et al. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989;7:1504-13.
18. Suit HD, Mankin HJ, Wood WC. Treatment of the patient with stage MO sarcoma of soft tissue. J Clin Oncol 1988;6:854-62.
19. Singer S, Corson JM, Gonin R, et al. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg 1994;219:165-73.
20. Antman KH. Adjuvant therapy of sarcomas of soft tissue. Semin Oncol 1977;24:556-60.
21. Schray MF, Gunderson LL, Sim FH, et al. Soft tissue sarcoma. Integration of brachytherapy, resection, and external irradiation. Cancer 1990;66:451-6.